Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?

Veure altres versions (1)

Introduction: Neuromyelitis optica (NMO) is a severe demyelinating disease that preferentially involves spinal cord and optic nerve. It is part of a spectrum of neurological conditions associated with antibodies to aquaporin-4 (AQP4). This study investigates the role of MRI where novel, more sensiti...

Descripció completa

Dades bibliogràfiques
Autors principals:	Downer, J, Leite, M, Carter, R, Palace, J, Küker, W, Quaghebeur, G
Format:	Journal article
Idioma:	English
Publicat:	2012

Ítems similars

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?
per: Downer, J, et al.
Publicat: (2012)

NMO-IgG in the diagnosis of neuromyelitis optica.
per: Jarius, S, et al.
Publicat: (2007)

Neuromyelitis Optica (NMO) — Study Review
per: Justyna Chojdak-Łukasiewicz
Publicat: (2021-06-01)

Spinal cord MRI features in neuromyelitis optica (NMO): characteristics and relationship with severity and recovery in longitudinally extensive transverse myelitis (LETM) attacks
per: Murchison, A, et al.
Publicat: (2013)

An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica
per: Littleton, E, et al.
Publicat: (2006)

Autoimmune thyroiditis associated with neuromyelitis optica (NMO)
per: Sudulagunta, Sreenivasa Rao, et al.
Publicat: (2015-11-01)

NMO-DBr: the Brazilian Neuromyelitis Optica Database System
per: Marco A. Lana-Peixoto, et al.
Publicat: (2011-08-01)

Differential diagnosis of neuromyelitis optica spectrum disorders
per: Sung-Min Kim, et al.
Publicat: (2017-07-01)

CAN MRI BE USED AS A DIAGNOSTIC TOOL IN NEUROMYELITIS OPTICA SPECTRUM DISORDER?
per: Matthews, L, et al.
Publicat: (2012)

Magnetic resonance imaging in neuromyelitis optica.
per: Tackley, G, et al.
Publicat: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
per: Matthews, L, et al.
Publicat: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
per: Matthews, L, et al.
Publicat: (2013)

Neuromyelitis optica spectrum disorder and multiple sclerosis can be distinguished on the basis of MRI brain lesion characteristics
per: Matthews, L, et al.
Publicat: (2012)

Influence of pregnancy on neuromyelitis optica spectrum disorder.
per: Kim, W, et al.
Publicat: (2012)

LONG TERM OUTCOME IN NEUROMYELITIS OPTICA: LESSONS FROM 6 YEARS OF THE UK NMO STUDY
per: Jacob, A, et al.
Publicat: (2009)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
per: Collongues, N, et al.
Publicat: (2013)

Racial differences in neuromyelitis optica spectrum disorder
per: Kim, S, et al.
Publicat: (2018)

Delayed diagnosis of the neuromyelitis optica spectrum disorder
per: S. A. Dzhukkaeva, et al.
Publicat: (2023-08-01)

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
per: Kitley, J, et al.
Publicat: (2014)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
per: Nour, M, et al.
Publicat: (2014)

Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing
per: Jarius, S, et al.
Publicat: (2007)

Revised diagnostic criteria for neuromyelitis optica--incorporation of NMO-IgG status.
per: Jarius, S, et al.
Publicat: (2007)

Neuromyelitis optica spectrum disorder
per: Simon Broadley, et al.
Publicat: (2017-09-01)

NEUROMYELITIS OPTICA SPECTRUM DISORDER AND CMV RETINITIS: A CASE REPORT
per: George, J, et al.
Publicat: (2012)

The evolving clinical spectrum of neuromyelitis optica
per: Viegas, S, et al.
Publicat: (2008)

Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience
per: Mohammad Hossein Harirchian, et al.
Publicat: (2015-02-01)

Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
per: Matthews, L, et al.
Publicat: (2013)

Devic's neuromyelitis optica: Prognostic implications of NMO IgG status in Turkish patients
per: Akman-Demir, G, et al.
Publicat: (2008)

Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica Soroprevalência do anticorpo NMO-IgG em pacientes brasileiros com neuromielite óptica
per: Tarso Adoni, et al.
Publicat: (2008-06-01)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
per: Viegas, S, et al.
Publicat: (2009)

Use of mitoxantrone in neuromyelitis optica.
per: Kitley, J, et al.
Publicat: (2011)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
per: Kitley, J, et al.
Publicat: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
per: Kitley, J, et al.
Publicat: (2013)

Pediatric neuromyelitis optica spectrum disorder
per: Aman Mehta
Publicat: (2024-01-01)

Hypersomnia in Neuromyelitis Optica Spectrum Disorders
per: Hasan Can Güdek, et al.
Publicat: (2024-06-01)

Neuromyelitis optica spectrum disorders in children
per: N. F. Akhmetgaleeva, et al.
Publicat: (2024-08-01)

Relapsing neuromyelitis optica spectrum disorder
per: M Lakshmi Lavanya, et al.
Publicat: (2021-01-01)

Neuromyelitis optica spectrum disorders: An update
per: Lekha Pandit
Publicat: (2015-01-01)

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
per: Kitley, J, et al.
Publicat: (2013)

Characterizing mortality in patients with AQP4‐Ab + neuromyelitis optica spectrum disorder
per: Francis, A, et al.
Publicat: (2024)